|
|
|
|
| LEADER |
00000cam a2200000 i 4500 |
| 001 |
SCIDIR_on1267982038 |
| 003 |
OCoLC |
| 005 |
20231120010603.0 |
| 006 |
m o d |
| 007 |
cr cnu---unuuu |
| 008 |
210913s2021 enka o 000 0 eng d |
| 040 |
|
|
|a OPELS
|b eng
|e rda
|e pn
|c OPELS
|d OCLCO
|d OCLCF
|d SFB
|d SOE
|d OCLCO
|d OCLCQ
|d OCLCO
|d K6U
|d OCLCQ
|d OCLCO
|
| 019 |
|
|
|a 1287266691
|a 1287869971
|
| 020 |
|
|
|a 0128243260
|
| 020 |
|
|
|a 9780128243268
|
| 020 |
|
|
|z 9780128239285
|
| 020 |
|
|
|z 012823928X
|
| 035 |
|
|
|a (OCoLC)1267982038
|z (OCoLC)1287266691
|z (OCoLC)1287869971
|
| 050 |
|
4 |
|a RB155
|
| 082 |
0 |
4 |
|a 616.042
|2 23
|
| 245 |
0 |
0 |
|a Medical epigenetics /
|c edited by Trygve Tollefsbol.
|
| 250 |
|
|
|a Second edition.
|
| 264 |
|
1 |
|a London, United Kingdom :
|b Academic Press,
|c 2021.
|
| 300 |
|
|
|a 1 online resource (1 volume) :
|b illustrations (black and white, and color)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Translational Epigenetics ;
|v volume 29
|
| 588 |
0 |
|
|a Print version record.
|
| 505 |
0 |
|
|a Intro -- Medical Epigenetics -- Copyright -- Contents -- Contributors -- Preface -- Section A Overview -- Chapter 1 Advances in medical epigenetics -- Introduction -- Basic principles of epigenetics -- General medical aspects of epigenetics -- Epigenetics of system disorders -- Multisystem medical epigenetics -- Bioinformatics of epigenetic medicine -- Pharmacology of epigenetics -- Therapeutic epigenetics -- Medical epigenetics: Future prospects -- Conclusion -- References -- Section B General medical aspects of epigenetics -- Chapter 2 Environmental epigenetic epidemiology -- Introduction -- Malnutrition -- Environmental pollutants -- Air pollution -- Endocrine-disrupting chemicals -- Heavy metals -- Substance abuse -- Alcohol -- Tobacco smoking -- Marijuana smoking -- Opioids -- Infection -- Conclusions and perspectives -- Acknowledgment -- References -- Chapter 3 Lifestyle and preventive medical epigenetics -- Introduction -- Epigenetics -- How epigenetics influence risk of diseases -- How lifestyle determines epigenetics -- How knowledge on epigenetics could be used to prevent diseases -- Impact of dietary pattern on the epigenome -- Carbohydrates and epigenetic modifications -- Proteins and epigenetic modifications -- Fatty acids and epigenetic modifications -- Role of micronutrients in epigenetics -- Essential vitamins -- Mineral elements -- Bioactive compounds -- Exercise and epigenetics -- Environmental factors and epigenetic modification -- Lifestyle modification as a preventive tool for medical epigenetics -- Conclusion -- References -- Chapter 4 Environmental medical epigenetics: A review of epigenetically induced medical risks generated from exposures in our air, f ... -- Introduction -- Allergens -- Aeroallergens -- Food allergens -- Secondhand cigarette smoke and vaping -- Traffic-related air pollution -- PM 2.5.
|
| 505 |
8 |
|
|a Diesel exhaust particles -- Polycyclic aromatic hydrocarbons -- Trace metals -- Heavy metals -- Chromium -- Arsenic -- Lead -- Cadmium -- Endocrine-disrupting chemicals -- Bisphenol A -- Phthalates -- Parabens -- Flame retardants/polybrominated diphenyl ethers -- Pesticides and fungicides -- Vinclozolin -- Persistent organic pollutants and other pesticides -- Volatile organic compounds -- Farm exposure -- Diet -- Folic acid and other methyl donors -- Additional vitamin and antioxidant supplementation -- Dietary fat, sucrose -- Famine -- Conclusions/outstanding questions -- Glossary -- References -- Chapter 5 Behavioral medical epigenetics -- Introduction -- Impact of environmental factors on behavior -- Animal models and studies of human behavior -- Environmental stressors and epigenetic mediators of the stress response -- Nonepigenetic and alternate mechanisms of stress -- The HPA axis and the stress response -- Glucocorticoid signaling and epigenetics -- HPA axis genes: Genes that regulate glucocorticoid signaling -- Chronic stress and glucocorticoid resistance -- Glucocorticoid resistance and epigenetics -- HPA axis genes: Genes that regulate tissue-specific processes -- Environmental stressors and neurotransmitters -- Interconnectivity of the neurotransmitter systems -- The dopaminergic system -- Behavioral disorders associated with the dopaminergic system -- Evidence for glucocorticoid effect on dopaminergic transmission -- Glucocorticoids and dopamine in drug addiction -- Epigenetic mediators of glucocorticoids on dopamine-related behavior -- Adrenergic and noradrenergic systems -- Behavioral disorders associated with the adrenergic and noradrenergic system -- Evidence for glucocorticoid effect on adrenergic and noradrenergic transmission -- Epigenetic mediators of glucocorticoids on adrenaline- and noradrenaline-related behavior.
|
| 505 |
8 |
|
|a The serotonergic (5-HT) system -- Behavioral disorders associated with the serotonergic system -- Evidence for glucocorticoid effect on serotonergic transmission -- Epigenetic mediators of glucocorticoids on serotonin-related behavior -- Glutamate and GABA systems -- Behavioral disorders associated with the glutamate and GABA system -- Evidence for glucocorticoid effect on glutamate and GABA system -- Epigenetic mediators of glucocorticoids on glutamate and GABA-related behavior -- Conclusion -- References -- Chapter 6 Medical epigenetics and twins -- Introduction -- Monogenic disorders: Twin studies and the epigenetics of imprinting disorders -- Twin studies and Beckwith-Wiedemann syndrome -- Twin studies and Silver-Russell syndrome -- Twin studies and the epigenetics of multifactorial disorders -- Twin studies and the epigenetics of cardiovascular diseases -- Twin studies and the epigenetics of psychiatric disorders -- Twin studies and the epigenetics of autism -- Twin studies and the epigenetics of schizophrenia -- Twin studies and the epigenetics of depression -- Twin studies and the epigenetics of aging -- Twin studies and the epigenetics of metabolic traits and disease -- Body mass index -- Diabetes -- Twin studies and epigenetic mechanisms -- Rett syndrome -- Caveats -- Future directions -- Conclusions -- References -- Chapter 7 Epigenetic biomarkers of disease -- Introduction -- Epigenetic biomarkers -- Disruption of the "epigenetic machinery" in cancer -- Epigenetic mechanisms of acquired drug resistance -- Types of epigenetic modifications -- DNA methylation -- Noncoding RNAs (miRNAs) -- Histone modifications -- Chromatin remodeling -- Epigenetic biomarkers in cancer -- Diagnosis, prognosis, and drug response epigenetic biomarkers in solid biopsies -- Lung cancer -- Breast cancer -- Colorectal cancer -- Prostate cancer.
|
| 505 |
8 |
|
|a Diagnosis, prognosis, and drug response biomarkers in liquid biopsies -- Lung cancer -- Breast cancer -- Colorectal cancer -- Prostate cancer -- Head and neck squamous cell carcinoma -- Pancreatic cancer -- Melanoma -- Hepatocellular carcinoma -- Methods for assessing epigenetic changes for biomarkers -- Genome-wide epigenetic analysis -- Enrichment-based methods -- Bisulfite conversion-based methods -- Specific methods for 5hmC -- miRNA genome-wide profiling -- Locus-specific epigenetic analysis -- Pyrosequencing -- Targeted next-generation sequencing -- Amplicon melting-based method -- RT-PCR based for 5mC and 5hmC targeted screening -- Specific methods for liquid biopsy -- Bioinformatic analysis -- Clinical application of epigenetic biomarkers -- Epigenetic biomarkers in precision medicine -- Epigenetic plasticity as a therapeutic target -- Epigenomic modulation drugs -- Future perspectives -- Conclusion -- References -- Chapter 8 Prognostic epigenetics -- Introduction -- DNA methylation markers of cancer prognosis -- Histone modifications as markers of cancer prognosis -- Noncoding RNA prognostic markers in cancer -- Prognostic epigenetic markers in nonmalignant pathology -- The future -- Conflict of interest statement -- References -- Section C Epigenetics of system disorders -- Chapter 9 Autoimmune disease and epigenetics -- Autoimmune disease overview -- Autoimmune disease etiology -- Epigenetics and autoimmunity -- Epigenetic regulation of T cell subset differentiation -- DNA methylation and autoimmune disease -- DNA hypomethylation -- DNA hypermethylation -- DNA hydroxymethylation -- Histone modifications and autoimmune disease -- Histone acetylation -- Histone methylation -- RNA modifications in autoimmune disease -- Environmental epigenetics -- Environmental epigenetics and autoimmunity -- Xenobiotics and autoimmunity.
|
| 505 |
8 |
|
|a Mechanisms of xenobiotic-induced autoimmunity -- Xenobiotic-induced epigenetic changes and autoimmunity -- Trichloroethylene -- Trichloroethylene-mediated immunotoxicity -- Trichloroethylene and autoimmunity -- Trichloroethylene-induced autoimmunity in experimental models -- Trichloroethylene-mediated epigenetic changes in CD4 + T cells -- Conclusions -- References -- Chapter 10 Epigenetics of pulmonary diseases -- Introduction -- Epigenetic basics -- Epigenetics in disease -- Epigenetics in the lungs -- Epigenetics in pulmonary diseases -- Lung cancer -- Pulmonary hypertension -- Chronic obstructive pulmonary disease -- Idiopathic pulmonary fibrosis -- Tuberculosis -- Conclusion -- Grants -- Disclosures -- Author contributions -- References -- Chapter 11 Cardiovascular disorders and epigenetics -- Introduction -- Early heart development and the fetal origin of cardiovascular disease -- Epigenetic involvement in cardiovascular risk factors -- Smoking -- Age -- Hypertension -- Obesity and dyslipidemia -- Diabetes -- Epigenetics and cardiovascular disease -- Endothelial dysfunction and atherosclerosis -- Ischemic heart disease -- Stroke -- Vascular disease -- Cardiac hypertrophy -- Heart failure -- Epigenetic-based cardiovascular therapy -- Conclusion -- References -- Chapter 12 Epigenomics of intestinal disease -- Introduction -- Epigenetics and intestinal development -- Intestinal homeostasis and the microbiota -- Epigenetics, intestinal homeostasis, and the microbiota -- Microbiota-derived metabolites -- Diet and the intestinal epigenome -- Colon cancer -- Inflammatory bowel disease -- Irritable bowel syndrome -- Celiac disease -- Therapeutics -- Future directions -- Glossary -- Acknowledgments -- References -- Chapter 13 Epigenetics of skin disorders -- Immunologic skin diseases -- Introduction -- Epigenetics in systemic lupus erythematosus.
|
| 650 |
|
0 |
|a Medical genetics.
|
| 650 |
|
0 |
|a Epigenetics.
|
| 650 |
|
2 |
|a Genetics, Medical
|0 (DNLM)D005826
|
| 650 |
|
2 |
|a Epigenomics
|0 (DNLM)D057890
|
| 650 |
|
6 |
|a G�en�etique m�edicale.
|0 (CaQQLa)201-0001432
|
| 650 |
|
6 |
|a �Epig�en�etique.
|0 (CaQQLa)000270630
|
| 650 |
|
7 |
|a Epigenetics
|2 fast
|0 (OCoLC)fst01893642
|
| 650 |
|
7 |
|a Medical genetics
|2 fast
|0 (OCoLC)fst01014133
|
| 700 |
1 |
|
|a Tollefsbol, Trygve O.,
|e editor.
|
| 776 |
0 |
8 |
|i Print version:
|t Medical epigenetics.
|b Second edition.
|d Amsterdam : Academic Press, 2021
|z 9780128239285
|w (OCoLC)1259522885
|
| 830 |
|
0 |
|a Translational epigenetics series ;
|v v. 29.
|
| 856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780128239285
|z Texto completo
|
